MedPath

Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
Registration Number
NCT00041314
Lead Sponsor
Eastern Cooperative Oncology Group
Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

PURPOSE: Phase II trial to study the effectiveness of carboplatin, gemcitabine, and exisulind in treating patients who have advanced non-small cell lung cancer.

Detailed Description

OBJECTIVES:

* Determine the 18-month survival rate in patients with advanced non-small cell lung cancer treated with carboplatin, gemcitabine, and exisulind.

* Determine the feasibility and toxicity of this regimen in these patients.

* Determine the response rate, progression-free survival, and overall median survival of patients treated with this regimen.

OUTLINE: Patients receive gemcitabine IV over 30 minutes on days 1 and 8 and carboplatin IV over 30 minutes on day 1. Chemotherapy repeats every 21 days for up to 6 courses. Patients also receive oral exisulind twice daily beginning on day 1 of course 1 and continuing until disease progression or unacceptable toxicity occurs.

Patients are followed every 3 months for 2 years and then every 6 months for 2 years.

PROJECTED ACCRUAL: A total of 55 patients will be accrued for this study within 6 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (79)

University of Alabama at Birmingham Comprehensive Cancer Center

🇺🇸

Birmingham, Alabama, United States

CCOP - Scottsdale Oncology Program

🇺🇸

Scottsdale, Arizona, United States

City of Hope Comprehensive Cancer Center

🇺🇸

Duarte, California, United States

Veterans Affairs Medical Center - Palo Alto

🇺🇸

Palo Alto, California, United States

Stanford University Medical Center

🇺🇸

Stanford, California, United States

CCOP - Colorado Cancer Research Program, Inc.

🇺🇸

Denver, Colorado, United States

CCOP - Christiana Care Health Services

🇺🇸

Wilmington, Delaware, United States

MBCCOP-Howard University Cancer Center

🇺🇸

Washington, District of Columbia, United States

Veterans Affairs Medical Center - Gainesville

🇺🇸

Gainesville, Florida, United States

Veterans Affairs Medical Center - Miami

🇺🇸

Miami, Florida, United States

Scroll for more (69 remaining)
University of Alabama at Birmingham Comprehensive Cancer Center
🇺🇸Birmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.